Results 141 to 150 of about 36,199 (325)

Dictionary of pharmacoepidemiology [PDF]

British Journal of Clinical Pharmacology, 2001
Dictionary of pharmacoepidemiology by Bernard Begaud, published by Wiley & Sons, Price £45, ISBN. 0 471 80361 8 ‘When I use a word’, Humpty Dumpty said in rather a scornful tone, ‘it means just what I choose it to mean – neither more nor less’. Lewis Carroll, Through the Looking Glass. Pharmacoepidemiology is a relatively new discipline.
openaire   +2 more sources

Prevalence, treatment and burden of chronic spontaneous urticaria in five European countries

Journal of the European Academy of Dermatology and Venereology, EarlyView.
This study evaluates prevalence, treatment patterns, disease profile and burden in patients with chronic spontaneous urticaria (CSU) in five European countries (EU5: France, Germany, Italy, Spain and the United Kingdom [UK]). CU, chronic urticaria; ER, emergency room; GAD, General Anxiety Disorder‐7; HRU, healthcare resource use; HRQoL, health‐related ...
Maria‐Magdalena Balp, Kathryn Krupsky, Shaloo Gupta, Clementine Lienhard, Ravneet K. Kohli, Dhaval Patil, Florence Tétart, John Reed, Tariq El‐Shanawany   +8 more
wiley   +1 more source

Invited commentary on Stewart and Davis " 'Big data' in mental health research-current status and emerging possibilities" [PDF]

, 2016
No abstract ...
Hafferty, Jonathan D., McIntosh, Andrew M., Smith, Daniel J.   +2 more
core   +1 more source

Implementation of Lecanemab for Alzheimer's Disease Within the Veterans Health Administration: Facilitators and Barriers

Journal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Several amyloid targeting therapies have been approved for Alzheimer's disease (AD), including lecanemab (Leqembi). However, real‐world implementation of these drugs has uncovered significant challenges. Methods We conducted a national cross‐sectional survey of healthcare professionals from multiple disciplines participating in the ...
Alison J. O'Donnell, Alexandra T. Fortunato, Brittany L. Spitznogle, Naveen M. Reddy, Shaye A. Kerper, Steven M. Handler   +5 more
wiley   +1 more source

Trends and variation in issuance of high‐cost narcolepsy drugs by NHS England organisations and regions from 2019 to 2022

Journal of Sleep Research, EarlyView.
Summary Clinicians and people with narcolepsy report varied access to higher‐cost narcolepsy treatments in England associated with variations in national and local commissioning. There are no publicly available data quantifying use of these drugs to support policy decisions. We therefore aimed to describe national, regional and local prescribing trends
Frederick van Someren, Milan Wiedemann, Charlotte Warren‐Gash, Martina Sykorova, Hema Mistry, Michelle A. Miller, Guy Leschziner, Ellen Nolte, Aurélien Belot, Ian E. Smith, Tim Quinnell, Sofia H. Eriksson, Helen Strongman   +12 more
wiley   +1 more source

Fluoroquinolones and the risk of aortic aneurysm or dissection: A population-based propensity score-matched German cohort study. [PDF]

Pharmacotherapy
Abstract Objective To investigate the risk of aortic aneurysm or dissection associated with fluoroquinolone (FQ) prescription compared to macrolides in German routine health care data in order to replicate the recent study (Pharmacotherapy 2023;43:883) extending the results by contributing evidence for six additional broad‐spectrum antibiotic classes ...
Wicherski J, Peltner J, Becker C, Schüssel K, Brückner G, Schlotmann A, Schröder H, Kern WV, Haenisch B.   +8 more
europepmc   +2 more sources

The use of medication by the Spanish population [PDF]

, 1997
Producción CientíficaThe aim of the study was to assess patterns of the use of medicines by the general population older than 0 years. The study was based on the information contained in the computerized database from the 1993 Spanish Household Health ...
Prada Puentes, Carlos, Río, María del Carmen del, Álvarez González, Francisco Javier   +2 more
core   +2 more sources

Cutaneous reactions during treatment with Nifurtimox or Benznidazole among Trypanosoma cruzi seropositive adults without symptomatic cardiomyopathy: A safety sub analysis of a placebo‐controlled randomised trial

Tropical Medicine &International Health, EarlyView.
Abstract Objectives To determine, in a randomised placebo‐controlled trial, if cutaneous adverse reactions during treatment (CARDT) with Benznidazole occur as often as with Nifurtimox, and whether the dose and duration of treatment change that frequency.
Juan Carlos Villar, María Fernanda Saavedra, Pablo Andrés Bermúdez, Eliana Váquiro Herrera, Skarlet Marcell Vásquez, Helena Arango, Antonia Camacho, Mario Javier Olivera   +7 more
wiley   +1 more source

Characteristics and Outcomes of Patients on Tofacitinib for Alopecia Areata or Rheumatoid Arthritis: A Retrospective Cohort Study

Pharmacoepidemiology
Tofacitinib is a Janus kinase inhibitor (JAKi) that is used off-label for the treatment of alopecia areata (AA). Its boxed warning includes an increased risk of serious adverse events (SAEs) based on the results of a safety trial in rheumatoid arthritis (
Sarah Choe, Abhinav Birda, Jesse Salas, Olive Anagu, Natasha Mesinkovska   +4 more
doaj   +1 more source

Prescription opioid supply‐restricting policies and hospital use by people prescribed opioid medications, Victoria, 2018–22: a controlled interrupted time series analysis

Medical Journal of Australia, EarlyView.
Abstract Objectives To investigate the combined effect of two policies for reducing prescription opioid supply in Australia on hospital use by people prescribed opioids in primary care. Study design Retrospective data linkage study; controlled interrupted time series analysis of linked primary care electronic medication records and hospital admissions ...
Suzanne Nielsen, Louisa Picco, Bosco Rowland, Nadine E Andrew, Taya A Collyer, Samanta Lalic, Rachelle Buchbinder, Christopher Pearce, J Simon Bell, Dan I Lubman, Ting Xia   +10 more
wiley   +1 more source